Study for the effect of perioperative use of dexamethasone on donor's outcome in living donor renal transplantation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031137

Enrollment

Unknown

Registered

2020-03-22

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Living donor of kidney transplantation

Interventions

Dexamethasone Group:Injection of examethasone in perioperative period

Normal saline Group:Injection of normal saline in perioperative period

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The donors who intend to perform living relative kidney transplantation between April 2020 to December 2020 in the Renal Transplantation Center of the Department of Urology, West China Hospital of Sichuan University.

Exclusion criteria

Exclusion criteria: 1. With a history of taking dexamethasone one week before operation; 2. With a history of ulcerative enteritis; 3. Patients who used dexamethasone many times in perioperative periodnt. 4. Patients unwilling to participate in the experiment.

Design outcomes

Primary

Measure	Time frame
KIM-1;NGAL;	—

Secondary

Measure	Time frame
CRP;PCT;IL-2/6/8/10;sCr;Cystatin C;	—

Countries

China

Contacts

Public ContactTao Lin

Department of Urology, West China Hospital of Sichuan University

kidney5@163.com+86 18980602093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026